XORTX Therapeutics Inc.

XRTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001729214

SEC filings (opens in a new tab)

No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding XORTX Therapeutics Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of XRTX: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	4	5	+1
Shares	33.6K	25.4K	−8.17K (−24.3%)
Value	$45.0K	$30.0K	−$15.0K (−33.3%)

New holders (2)

Institutions that held XORTX Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to XRTX in Q3 2022
Institution	Shares	Value	% of portfolio
Advisor Group Holdings, Inc.	3,603	$4.00K	0.00%
Clearstead Advisors, LLC	2,500	$3.00K	0.00%

Sold out (1)

Institutions that held XORTX Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of XRTX in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
UBS Group AG	5,701	$8.00K